Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
S&P Biotech SPDR
(NY:
XBI
)
101.51
+1.37 (+1.37%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about S&P Biotech SPDR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
3 Pharma Stocks Yielding Over 3%
January 18, 2022
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.
Via
Talk Markets
9 Monster Stock Market Predictions – The Week Of Jan. 17
January 17, 2022
The chart for the SPX is looking more and more like a diamond pattern.
Via
Talk Markets
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.
Via
InvestorPlace
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
January 10, 2022
Pfizer and Bayer inked deals with several companies in gene-editing.
Via
Investor's Business Daily
Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations
January 03, 2022
It was another brutal year for cannabis stock investors in 2021 as the U.S. made very little regulatory progress on cannabis reform measures. Fortu...
Via
Benzinga
Top 10 Investment Themes For 2022
December 25, 2021
What are the investment trends going to look like for 2022?
Via
Talk Markets
ETF Battles: Which Biotech Stock ETF Is The Better Choice? - It's IBB Vs. XBI
December 23, 2021
A biotech clash between the iShares Biotechnology ETF and the SPDR S&P Biotech ETF.
Via
Talk Markets
Fear & Greed In The Biotech Sector
January 02, 2022
With rates rising, widespread tax-loss selling, and fund manager’s either closing the books for 2021 or just closing down altogether, the market has entered a major risk off phase and biotech stocks...
Via
Talk Markets
Healthcare Stocks Are Winners And Provide Diversification To Your Portfolio
December 30, 2021
As we have written their year many times speculative small cap biotechs have not done well in 2021 since they peaked in February.
Via
Talk Markets
The Bear Market Is Already Here – But Not For Dividend Investors
December 22, 2021
While the broad stock market indices remain at near-record levels, there are sectors of the market that have dropped into correction or even bear market territory over recent months.
Via
Talk Markets
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
December 22, 2021
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.
Via
Talk Markets
10 Bargain Stocks to Buy After Falling 30% in 2021
December 20, 2021
If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill.
Via
InvestorPlace
Biotech Playbook 2021: No Help From Small Caps In Q4
December 14, 2021
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...
Via
Talk Markets
8 Monster Stock Market Predictions – The Week Of December 13, 2021 Edition
December 12, 2021
Via
Talk Markets
5 Top-Ranked ETFs to Buy At Bargain Prices
December 08, 2021
The beaten-down prices have charged up investors to snap up ETFs on the cheap. Investors could definitely look to these products for outsized gains over the longer term.
Via
Talk Markets
How Did Healthcare Stocks Perform Over This Volatile Month?
December 06, 2021
It’s been a rough month for small-cap biotech stocks amidst a general correction in the market which brought general indices down about 10%.
Via
Talk Markets
Tuesday Talk: O(micron) - Pow(ell)!
November 30, 2021
As Wall St. investors await the market open Tuesday, futures dive on Omicron concerns as well as anticipation surrounding Yellen and Powell's Senate testimony this morning.
Via
Talk Markets
Stocks Rise On November 29 On Predictable Volatility Crush
November 29, 2021
Stocks jumped on November 29 as volatility came down sharply.
Via
Talk Markets
COVID Is Back Disrupting Markets And Causing More Sector Uncertainty
November 29, 2021
Just when you were having an enjoyable four day weekend cruising along the interminable bull market COVID is back disrupting trends. Healthcare stocks held up reasonably well .Will there be new respect...
Via
Talk Markets
Biotech Stocks are Due for a Rally
November 22, 2021
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.
Via
Talk Markets
Looking for Growth in Small and Mid Cap Life Science Stocks
November 15, 2021
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.
Via
Talk Markets
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
November 06, 2021
There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see...
Via
Talk Markets
Wednesdays With Wedbush On PreMarket Prep Plus
November 03, 2021
On the PreMarket Prep Plus "Wednesday’s With Wedbush" segment, Sahak Manuelian, managing director and head of equi...
Via
Benzinga
15 Charts All Traders Should Look At Every Morning
September 30, 2021
One of the hardest things to do as a day trader is gathering all the necessary information to execute profitable trades. Below are the to...
Via
Benzinga
Look For The Q4 Biotech Bounce In Mid-Small Caps
September 17, 2021
Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best...
Via
Talk Markets
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
September 09, 2021
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.
Via
Talk Markets
Healthcare Stocks Hit New Highs but Small Caps Lag
August 23, 2021
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.
Via
Talk Markets
ETF Reflections: US Stocks
August 21, 2021
I'm a bear. So the longer they prop this dreck up, the greater the fall. Suits me!
Via
Talk Markets
Biotech ETFs To Benefit From Latest Booster Update
August 21, 2021
Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from...
Via
Talk Markets
Exposures
COVID-19
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
August 16, 2021
On Monday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw unusual options activity. After the option alert, the stock price moved down to $122.44. Sentiment...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.